Fri., Oct. 22
11:30 a.m.–12:30 p.m.
Each of the following flash talks will last approximately 10 minutes. Join us on Zoom.
Stress management and self-care
Jamie Li, B.S., WSU Pullman Psychology Clinic
Discuss the biological and psychological impact of stress. Learn strategies you can utilize to manage stress and increase well-being.
Updates on the treatment of Chlamydia
Lexie Powell, PharmD, College of Pharmacy and Pharmaceutical Sciences
Overview of recommended treatments for chlamydia following the CDC’s July 2021 STI Treatment Guideline Updates.
Exploring how field safety concerns may impact diversity, equity and inclusion in higher education
Doug Call, Regents Professor, School for Global Health
This discussion is centered on how field safety (inclusive of biological and physical sciences, clinical sciences and extension activities) may be limiting diversity, equity and inclusion in undergraduate, graduate, and professional education.
Healthy pets make healthy owners
Jessica Bell, DVM, assistant professor, veterinary clinical sciences, WSU Veterinary Teaching Hospital, College of Veterinary Medicine
The human and animal bond is an amazing relationship to try and understand. The purpose of animals—once centered around food, clothing, and work—has grown so that animals have become members of our families. As veterinarians, we want to help protect that bond not only for the benefit of ourselves, but for our pets as well. Companion animals have become a very important part of our everyday lives. The need to take care of a pet often is more important to a person then taking care of their own needs. How do relationships with pets benefit us mentally, physically, and emotionally?
Alcohol use disorder: Why is the gold-standard treatment outcome shifting from complete abstinence to low-risk drinking?
André Miguel, PhD., Elson S. Floyd College of Medicine
Despite consequences related to alcohol use, some individuals who drink heavily do not seek alcohol treatment. The reason: They do not want to stop drinking, but are instead interested in reducing their heavy drinking. Low-risk drinking outcomes are 1) achievable during treatment, 2) associated with significant physical and psychosocial long-term improvements, and 3) accepted by the FDA as a valid outcome measure for clinical trials evaluating pharmacological treatments for alcohol use disorders. Furthermore, low-risk drinking is a far more acceptable goal for many patients interested in some type of treatment and may prompt many heavy drinkers who are contemplating treatment to seek a low-barrier treatment with non-abstinence-based goals.
Zoom ID and passcode
Link to join
930 7075 7785
ADA accessibility accommodations
Available by request. Make your requests before September 28.